A randomized, double-blind, parallel group, placebo controlled Phase II study to evaluate the safety and efficacy of two inhaled LASAG regimens and Placebo, applied three times daily in adult hospitalized patients with acute serious influenza
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Glycine/lysine-acetylsalicylate (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Activaero GmbH; Vectura
- 24 Jan 2013 New trial record